LDH isozyme as a prognostic factor for patients with metastatic clear cell renal cell carcinoma (mCRCC)

被引：0
|
作者：
Takeda, H. [1 ]
Kimura, G. [1 ]
Taniuchi, M. [1 ]
Hasegawa, H. [1 ]
Mikami, H. [1 ]
Akatsuka, J. [1 ]
Endo, Y. [1 ]
Toyama, Y. [1 ]
Kondo, Y. [1 ]
机构：
[1] Nippon Med Sch, Main Hosp, Urol Dept, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
251P
引用
收藏
页码：S1570 / S1570
页数：1
相关论文
共 50 条
  • [1] Association of serum lactate dehydrogenase (LDH) isozyme with prognosis of patients with metastatic clear cell renal cell carcinoma (mCRCC).
    Takeda, Hayato
    Kimura, Go
    Akatsuka, Jun
    Endo, Yuki
    Yanagi, Masato
    Mikami, Hikaru
    Hasegawa, Hiroya
    Katsu, Akifumi
    Funato, Ryota
    Taniuchi, Mami
    Toyama, Yuka
    Kondo, Yukihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [2] A comprehensive prognostic stratification for patients with metastatic renal clear cell carcinoma
    Cho, Kang Su
    Choi, Young Deuk
    Kim, Se Joong
    Kim, Chun Il
    Chung, Byung Ha
    Seong, Do Hwan
    Lee, Dong Hyeon
    Cho, Jin Seon
    Cho, In Rae
    Hong, Sung Joon
    YONSEI MEDICAL JOURNAL, 2008, 49 (03) : 451 - 458
  • [3] Anemia in patients ≥ 75 years with metastatic clear cell renal cell carcinoma: an important poor prognostic factor in the international metastatic renal cell carcinoma database consortium model
    Ryuichi Mizuno
    Yota Yasumizu
    Nobuyuki Tanaka
    Toshikazu Takeda
    Shinya Morita
    Kazuhiro Matsumoto
    Takeo Kosaka
    Hiroshi Asanuma
    Mototsugu Oya
    BMC Urology, 24
  • [4] Anemia in patients ≥ 75 years with metastatic clear cell renal cell carcinoma: an important poor prognostic factor in the international metastatic renal cell carcinoma database consortium model
    Mizuno, Ryuichi
    Yasumizu, Yota
    Tanaka, Nobuyuki
    Takeda, Toshikazu
    Morita, Shinya
    Matsumoto, Kazuhiro
    Kosaka, Takeo
    Asanuma, Hiroshi
    Oya, Mototsugu
    BMC UROLOGY, 2024, 24 (01)
  • [5] Ezrin is a prognostic biomarker in patients with clear cell metastatic renal cell carcinoma receiving sunitinib
    Cetin, Bulent
    Gonul, Ipek Isik
    Gumusay, Ozge
    Afsar, Baris
    Bilgetekin, Irem
    Ozet, Ahmet
    Uner, Aytug
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (02) : 408 - 413
  • [6] Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma
    Gu, Liangyou
    Ma, Xin
    Xie, Yongpeng
    Li, Hongzhao
    Wang, Lei
    Chen, Luyao
    Zhao, Wenlei
    Zhang, Yu
    Zhang, Xu
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E369 - E377
  • [7] Prognostic value of granulocyte colony-stimulating factor in patients with non-metastatic clear cell renal cell carcinoma
    Liu, Zheng
    Zhu, Yu
    Wang, Yiwei
    Fu, Qiang
    Fu, Hangcheng
    Wang, Zewei
    Zhang, Junyu
    Li, Gaoxiang
    Xu, Jiejie
    Dai, Bo
    ONCOTARGET, 2017, 8 (41) : 69961 - 69971
  • [8] Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma
    Suppiah, Revathi
    Shaheen, Philip E.
    Elson, Paul
    Misbah, Seema A.
    Wood, Laura
    Motzer, Robert J.
    Negrier, Slyvie
    Andresen, Steven W.
    Bukowski, Ronald M.
    CANCER, 2006, 107 (08) : 1793 - 1800
  • [9] Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma
    Tsimafeyeu, Ilya V.
    Demidov, Lev V.
    Madzhuga, Albina V.
    Somonova, Oksana V.
    Yelizarova, Anna L.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
  • [10] Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma
    Ilya V Tsimafeyeu
    Lev V Demidov
    Albina V Madzhuga
    Oksana V Somonova
    Anna L Yelizarova
    Journal of Experimental & Clinical Cancer Research, 28
12345